Monogram Technologies sends stockholders email with FAQs regarding proposed Zimmer Biomet acquisition

Monogram Technologies Inc.

Email sent on July 30, 2025 directs stockholders to FAQ section on company's Investor Relations page.
FAQs relate to proposed acquisition by Zimmer Biomet Holdings, Inc. announced on July 14, 2025.
The email is furnished as Exhibit 99.1 to this Form 8-K.
Company's common stock trades on Nasdaq under ticker MGRM.
Benjamin Sexson, CEO, signed the report on July 30, 2025.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.